CS03 - Journeys of People Living with Type 1 Diabetes: A Breakthrough T1D Educational Symposium

Sunday, August 10, 2025

5:45 PM - 7:15 PM MST

CE/CME Hours: 1.0 CE

Universal Activity Number (Live): JA4008258-9999-25-250-L01-P

Type 1 diabetes (T1D) is a chronic, life-threatening autoimmune disease that impacts nearly 9.5 million Americans of all ages. While often diagnosed in childhood, many cases go undetected due to subtle symptoms or a lack of noticeable signs, or diagnosis may be delayed until a serious complication arises.

With groundbreaking treatment strategies available and more on the horizon, it is vital for diabetes care and education specialists to grasp the complexities of T1D and to enhance their expertise in screening, staging, and management for both those living with T1D and those at risk.

This dynamic symposium offers an engaging blend of interactive and educational components designed to improve recognition and staging of T1D, and understanding of new and emerging management strategies.

For more information and to register, please visit: https://www.medscape.org/symposium/t1d-screening

Doors will open at 5:30 PM. Please note that food will be available on a first-come, first-served basis.

This program is jointly provided by the Association of Diabetes Care & Education Specialists, Breakthrough T1D, and Medscape.

Disclosure(s):

Anastasia Albanese-O'Neill, PhD, APRN, CDCES: No financial relationships to disclose

Peter Senior, MBBS, PhD, FRCP: Abbott, Bayer, Dexcom, DiogenX, GSK, Insulet, Novo, Sanofi, Vertex, Ypsomed: Consultant / Advisory Board (Ongoing); Abbott, Dexcom,GSK,Novo, Sanofi, Vertex: Speakers' Bureau (Ongoing); Novo Nordisk, Eli Lily: Research (Ongoing)

Bithika Thompson, MD: No financial relationships to disclose

Speaker(s)

Anastasia Albanese-O'Neill, PhD, APRN, CDCES (she/her/hers)

Vice President, Medical Affairs
Breakthrough T1D

Disclosure(s): No financial relationships to disclose
Peter Senior, MBBS, PhD, FRCP

Professor, Division of Endocrinology & Metabolism Charles A. Allard Chair in Diabetes Research Director, Alberta Diabetes Institute
University of Alberta

Disclosure(s): Abbott, Bayer, Dexcom, DiogenX, GSK, Insulet, Novo, Sanofi, Vertex, Ypsomed: Consultant / Advisory Board (Ongoing); Abbott, Dexcom,GSK,Novo, Sanofi, Vertex: Speakers' Bureau (Ongoing); Novo Nordisk, Eli Lily: Research (Ongoing)
Bithika Thompson, MD

Chair of Endocrinology Associate Professor, Medicine
Mayo Clinic College of Medicine and Science

Disclosure(s): No financial relationships to disclose